Aridis Pharma nearly doubles after its antibody cocktail retains effectiveness against Omicron variant
Aridis Pharmaceuticals(NASDAQ:ARDS) soars 95.7% premarket after announcing that its fully human mono
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial